DEBRA LUPEIKA
Allopathic & Osteopathic Physicians|Family Medicine REDDING, CA NPI 1780697607
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine CA Amgen Inc. All categories
General Payments — all program years on this page
$348.13
- Category: General Payments
- Program years: PY2018–2024
- Record count: 15
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $248.04 across 10 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $248.04 | 10 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $117.20 | 4 |
| PFIZER INC. | $60.50 | 2 |
| GlaxoSmithKline, LLC. | $31.93 | 2 |
| Mylan Specialty L.P. | $21.12 | 1 |
| Lilly USA, LLC | $17.29 | 1 |
By program year
Records — PY2024 (10)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1111638894 | Amgen Inc. | $30.93 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111638896 | Amgen Inc. | $29.04 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111638898 | Amgen Inc. | $34.28 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111638900 | Amgen Inc. | $22.95 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116443059 | GlaxoSmithKline, LLC. | $16.41 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116486589 | GlaxoSmithKline, LLC. | $15.52 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1130878064 | PFIZER INC. | $31.08 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131588160 | PFIZER INC. | $29.42 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1136152265 | Lilly USA, LLC | $17.29 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147291426 | Mylan Specialty L.P. | $21.12 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.